William E. Kennard - Mar 11, 2025 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Taylor Jansen, Authorized Signer
Stock symbol
MET
Transactions as of
Mar 11, 2025
Transactions value $
$22,829
Form type
4
Date filed
3/13/2025, 04:19 PM
Previous filing
Mar 5, 2025
Next filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $22.8K +291 +0.69% $78.45 42.2K Mar 11, 2025 Direct F1
holding MET Common Stock 10 Mar 11, 2025 By the MetLife Policyholder Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
F2 Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.